GSK raises $1.24 billion from latest Haleon stake sale

Reuters

Published Jan 17, 2024 07:18

(Reuters) - British drugmaker GSK said on Wednesday it had raised 978 million pounds ($1.24 billion) from a discounted stake sale in Haleon (LON:HLN), cutting its shareholding to 4.2% in the world's largest standalone consumer healthcare firm.